Do not use in horses intended for human consumption. Not for human use. Hyalovet Injection must not be administered intravascularly.
There is currently no manufacturer warning information available for this drug.
There is currently no usage information available for this product. We apologize for any inconvenience.
Hyaluronic acid is the prototype of a wide range of saccharide biopolymers (glycosaminoglycans or mucopolysaccharides) consisting of repeating disaccharide units of N-acetyl-D-glucosamine and D-glucuronic acid linked by beta 1-3 and beta 1-4 glycosidic bonds. A component of all mammalian connective tissue, hyaluronic acid confers viscoelastic and lubricating properties to synovial fluid1 and structural integrity to cartilage matrix2. As a therapeutic agent, hyaluronic acid injected into arthritic joints has been shown, in a variety of animal model systems including horses3, to improve joint function and to activate tissue repair processes in articular cartilage.
Hyalovet (hyaluronate sodium) is clear, colorless, viscous solution of a specific fraction of highly purified hyaluronic acid obtained by a molecular filtration procedure from biological material (rooster combs). The specific hyaluronic acid fraction from which Hyalovet is made has a high degree of molecular definition with an average molecular weight of 500,000-730,000 D.
Each filled 2 mL glass syringe or 2 mL glass vial contains:
Hyaluronate sodium………………………………….20.0 mg
Sodium chloride……………………………………….17.0 mg
Monobasic sodium phosphate………………………0.1 mg
Dibasic sodium phosphate……………………………1.2 mg
Water for injection…………………………………q.s., 2 mL